DK1287348T3 - Fremgangsmåde og anordning til kvalitativ og/eller kvantitativ bestemmelse af et protein- og/eller peptidmönster af en væskepröve, som udtages fra den menneskelige eller animalske krop - Google Patents

Fremgangsmåde og anordning til kvalitativ og/eller kvantitativ bestemmelse af et protein- og/eller peptidmönster af en væskepröve, som udtages fra den menneskelige eller animalske krop

Info

Publication number
DK1287348T3
DK1287348T3 DK01943018T DK01943018T DK1287348T3 DK 1287348 T3 DK1287348 T3 DK 1287348T3 DK 01943018 T DK01943018 T DK 01943018T DK 01943018 T DK01943018 T DK 01943018T DK 1287348 T3 DK1287348 T3 DK 1287348T3
Authority
DK
Denmark
Prior art keywords
protein
human
animal body
qualitatively
liquid sample
Prior art date
Application number
DK01943018T
Other languages
English (en)
Inventor
Harald Mischak
Hermann Haller
Original Assignee
Mosaiques Diagnostics & Therap
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7640773&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1287348(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mosaiques Diagnostics & Therap filed Critical Mosaiques Diagnostics & Therap
Application granted granted Critical
Publication of DK1287348T3 publication Critical patent/DK1287348T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416—Systems
    • G01N27/447—Systems using electrophoresis
    • G01N27/44704—Details; Accessories
    • G01N27/44717—Arrangements for investigating the separated zones, e.g. localising zones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Electrochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK01943018T 2000-05-04 2001-05-04 Fremgangsmåde og anordning til kvalitativ og/eller kvantitativ bestemmelse af et protein- og/eller peptidmönster af en væskepröve, som udtages fra den menneskelige eller animalske krop DK1287348T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10021737A DE10021737C2 (de) 2000-05-04 2000-05-04 Verfahren und Vorrichtung zur qualitativen und/oder quantitativen Bestimmung eines Protein- und/oder Peptidmusters einer Flüssigkeitsprobe, die dem menschlichen oder tierischen Körper entnommen wird

Publications (1)

Publication Number Publication Date
DK1287348T3 true DK1287348T3 (da) 2006-05-29

Family

ID=7640773

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01943018T DK1287348T3 (da) 2000-05-04 2001-05-04 Fremgangsmåde og anordning til kvalitativ og/eller kvantitativ bestemmelse af et protein- og/eller peptidmönster af en væskepröve, som udtages fra den menneskelige eller animalske krop

Country Status (8)

Country Link
US (1) US7258775B2 (da)
EP (2) EP1287348B1 (da)
JP (1) JP2003532115A (da)
AT (1) ATE316652T1 (da)
DE (2) DE10021737C2 (da)
DK (1) DK1287348T3 (da)
ES (1) ES2256255T3 (da)
WO (1) WO2001084140A2 (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10021737C2 (de) 2000-05-04 2002-10-17 Hermann Haller Verfahren und Vorrichtung zur qualitativen und/oder quantitativen Bestimmung eines Protein- und/oder Peptidmusters einer Flüssigkeitsprobe, die dem menschlichen oder tierischen Körper entnommen wird
KR20030051435A (ko) 2000-06-19 2003-06-25 코렐로직 시스템즈, 인크. 분류화의 발견적 방법
CN1484806A (zh) 2000-07-18 2004-03-24 �����弪��ϵͳ��˾ 基于隐含模式用于从生物数据中识别生物状态的方法
CN1623091A (zh) 2000-11-16 2005-06-01 赛弗根生物***股份有限公司 质谱分析方法
AU2003261273A1 (en) 2002-07-29 2004-02-16 Correlogic Systems, Inc. Quality assurance for high-throughput bioassay methods
DE10304106A1 (de) * 2003-01-31 2004-08-26 Mosaiques Diagnostics And Therapeutics Ag Verfahren und Vorrichtung zur qualitativen und/oder quantitativen Bestimmung eines Protein- und/oder Peptidmusters einer Flüssigkeitsprobe, die dem menschlichen oder tierischen Körper entnommen wird
US20040236603A1 (en) * 2003-05-22 2004-11-25 Biospect, Inc. System of analyzing complex mixtures of biological and other fluids to identify biological state information
US7425700B2 (en) 2003-05-22 2008-09-16 Stults John T Systems and methods for discovery and analysis of markers
US7072772B2 (en) * 2003-06-12 2006-07-04 Predicant Bioscience, Inc. Method and apparatus for modeling mass spectrometer lineshapes
US20050255606A1 (en) * 2004-05-13 2005-11-17 Biospect, Inc., A California Corporation Methods for accurate component intensity extraction from separations-mass spectrometry data
WO2005028500A1 (ja) * 2003-09-05 2005-03-31 Toray Industries, Inc. 生体成分の組成が変化した溶液の調整方法
DE10341193A1 (de) * 2003-09-06 2005-03-31 Mosaiques Diagnostics And Therapeutics Ag Vorrichtung und Verfahren zur quantitativen Auswertung der in einer Körperflüssigkeitsprobe enthaltenden Polypeptide sowie Marker zur Erkennung von pathologischen Zuständen
WO2005060608A2 (en) 2003-12-11 2005-07-07 Correlogic Systems, Inc. Method of diagnosing biological states through the use of a centralized, adaptive model, and remote sample processing
US20050244973A1 (en) * 2004-04-29 2005-11-03 Predicant Biosciences, Inc. Biological patterns for diagnosis and treatment of cancer
US20060286602A1 (en) * 2004-05-10 2006-12-21 Harald Mischak Method and markers for the diagnosis of renal diseases
DE102004042530B4 (de) * 2004-09-02 2006-10-19 Mosaiques Diagnostics And Therapeutics Ag Verfahren zur Diagnose von Arteriosklerose
AU2006231597B2 (en) * 2005-04-06 2011-11-17 Mosaiques Diagnostics And Therapeutics Ag Polypeptide marker for diagnosing Alzheimer's disease
WO2006106129A2 (de) 2005-04-07 2006-10-12 Mosaiques Diagnostics And Therapeutics Ag Polypeptidmarker zur diagnose von prostatakrebs
EP1896856A1 (de) * 2005-06-29 2008-03-12 mosaiques diagnostics and therapeutics AG Polypeptidmarker zur frühzeitigen erkennung der rejektion von transplantierten nieren
EP1757939A1 (de) 2005-08-26 2007-02-28 mosaiques diagnostics and therapeutics AG Polypeptidmarker zur Diagnose von Blasenkrebs
JP4840804B2 (ja) 2006-01-20 2011-12-21 学校法人慶應義塾 酸化ストレスの判定方法
WO2008127376A2 (en) * 2006-10-17 2008-10-23 The Regents Of The University Of California Biological cell sorting and characterization using aerosol mass spectrometry
BRPI0808703A2 (pt) * 2007-03-07 2014-09-02 Mosaiques Diagnostics & Therap Processo para padronização da concentração de componentes para análise em uma amostram de urina
EP1972940A1 (de) * 2007-03-14 2008-09-24 mosaiques diagnostics and therapeutics AG Verfahren und Marker zur Diagnose von Nierenerkrankungen
US20080250032A1 (en) * 2007-04-04 2008-10-09 International Business Machines Corporation Method and system for efficiently saving and retrieving values of a large number of resource variables using a small repository
WO2008141285A2 (en) * 2007-05-11 2008-11-20 The Institutes For Pharmaceutical Discovery, Llc Methods for early diagnosis of kidney disease
EP2637020A3 (en) 2007-06-29 2014-01-08 Correlogic Systems Inc. Predictive markers for ovarian cancer
WO2009047280A2 (de) * 2007-10-09 2009-04-16 Mosaiques Diagnostics And Therapeutics Ag Polypeptidmarker zur diagnose von prostatakrebs
EP2051078A1 (de) * 2007-10-19 2009-04-22 mosaiques diagnostics and therapeutics AG Verfahren und Marker zur Diagnose von Diabetes Mellitus
WO2009115570A2 (de) * 2008-03-19 2009-09-24 Mosaiques Diagnostics And Therapeutics Ag Verfahren und marker zur diagnose von tubulären nierenschäden und -erkrankungen
US20110214990A1 (en) * 2008-09-17 2011-09-08 Mosaiques Diagnostics And Therapeutics Ag Kidney cell carcinoma
US20120118737A1 (en) 2009-07-02 2012-05-17 Harald Mischak Method And Markers For Diagnosing Acute Renal Failure
US20120241321A1 (en) 2009-09-14 2012-09-27 Harald Mischak Polypeptide marker for diagnosing and assessing vascular diseases
EP2649450A1 (de) 2010-12-10 2013-10-16 Mosaiques Diagnostics And Therapeutics AG Verfahren und marker zur diagnose einer gallengangsstriktur und eines cholangiozellulären karzinoms im gallensaft
WO2012123527A1 (de) 2011-03-15 2012-09-20 Mosaiques Diagnostics And Therapeutics Ag Verfahren und marker zur diagnose subklinischer und klinischer formen der t-zellvermittelten tubulointerstitiellen rejektion nach nierentransplantation
US20150065391A1 (en) 2012-01-30 2015-03-05 Mosaiques Diagnostics And Therapeutics Ag Polypeptide markers for diagnosis and assessment of heart failure
WO2013150132A2 (de) 2012-04-05 2013-10-10 Mosaiques Diagnostics And Therapeutics Ag Polypeptidmarker zur diagnostik und beurteilung von schlaganfällen
WO2015051343A1 (en) * 2013-10-03 2015-04-09 Northwestern University High throughput mass spectrometric analysis of proteome samples
EP3850370A1 (en) 2018-09-14 2021-07-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of amniotic fluid peptides for predicting postnatal renal function in congenital anomalies of the kidney and the urinary tract
WO2021026172A1 (en) 2019-08-05 2021-02-11 Seer, Inc. Systems and methods for sample preparation, data generation, and protein corona analysis
DE102021211272A1 (de) 2021-10-06 2023-04-06 Ruhr-Universität Bochum, Körperschaft des öffentlichen Rechts Zusammensetzung enthaltend künstliche Sauerstoffträger zur Verhinderung von Organschäden in Transplantationsorganen

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US499465A (en) * 1893-06-13 Letter-box
US4994165A (en) * 1989-02-16 1991-02-19 Cornell Research Foundation, Inc. Liquid junction coupling for capillary zone electrophoresis/ion spray spectrometry
US5843680A (en) 1992-01-31 1998-12-01 Biometric Imaging, Inc. Differential separation assay methods and test kits
DE4415480C2 (de) * 1994-05-02 1999-09-02 Bruker Daltonik Gmbh Vorrichtung und Verfahren zur massenspektrometrischen Untersuchung von Substanzgemischen durch Kopplung kapillarelektrophoretischer Separation (CE) mit Elektrospray-Ionisierung (ESI)
EA001033B1 (ru) * 1996-08-13 2000-08-28 Биовизион Гмбх Унд Ко.Кг Способ определения состояния организма посредством измерения пептидов
WO1998035226A1 (en) * 1997-02-06 1998-08-13 Board Of Regents, The University Of Texas System A novel sheathless interface for capillary electrophoresis/electrospray ionization-mass spectrometry using an in-capillary electrode
US6103537A (en) * 1997-10-02 2000-08-15 Aclara Biosciences, Inc. Capillary assays involving separation of free and bound species
WO1999046047A2 (en) * 1998-03-10 1999-09-16 Large Scale Proteomics Corporation Detection and characterization of microorganisms
EP1329513B1 (en) * 1998-08-25 2011-12-07 University of Washington Rapid quantitative analysis of proteins or protein function in complex mixtures
DE10021737C2 (de) 2000-05-04 2002-10-17 Hermann Haller Verfahren und Vorrichtung zur qualitativen und/oder quantitativen Bestimmung eines Protein- und/oder Peptidmusters einer Flüssigkeitsprobe, die dem menschlichen oder tierischen Körper entnommen wird

Also Published As

Publication number Publication date
EP1287348A2 (de) 2003-03-05
WO2001084140A2 (de) 2001-11-08
ATE316652T1 (de) 2006-02-15
EP1287348B1 (de) 2006-01-25
DE10021737A1 (de) 2001-11-15
DE50108801D1 (de) 2006-04-13
DE10021737C2 (de) 2002-10-17
US7258775B2 (en) 2007-08-21
EP1760463A2 (de) 2007-03-07
ES2256255T3 (es) 2006-07-16
WO2001084140A3 (de) 2002-05-10
US20030132114A1 (en) 2003-07-17
JP2003532115A (ja) 2003-10-28

Similar Documents

Publication Publication Date Title
DK1287348T3 (da) Fremgangsmåde og anordning til kvalitativ og/eller kvantitativ bestemmelse af et protein- og/eller peptidmönster af en væskepröve, som udtages fra den menneskelige eller animalske krop
Leak et al. Proteomic analysis of lymph
GB2430794A (en) Method and apparatus for identifying proteins in mixtures
Guzman Determination of immunoreactive gonadotropin-releasing hormone in serum and urine by on-line immunoaffinity capillary electrophoresis coupled to mass spectrometry
CA2482546A1 (en) Sampling probe microarray read out using electrospray mass spectrometry
WO2004042072A3 (en) Quantitative analysis of protein isoforms using matrix-assisted laser desorption/ionization time of flight mass spectrometry
ATE397891T1 (de) Methode und apparat zur konservierung von speichel für analysen
ATE394680T1 (de) Verfahren und vorrichtung zur charakterisierung von analyten
ATE344456T1 (de) Durch affinität ausgewählte unterschriftspeptide zur identifizierung und quantifizierung von proteinen
ATE251752T1 (de) Diagnostische vorrichtung und verfahren
DK2110666T3 (da) Hidtil ukendt fremgangsmåde til at detektere og analysere proteininteraktioner in vivo
DE50309809D1 (de) Scd40l, papp-a und plazentaler-wachstumsfaktor (pigf) als biochemische markerkombinationen bei kardiovaskulären erkrankungen
Østergaard et al. Bioanalytical interaction studies executed by preincubation affinity capillary electrophoresis
ATE411398T1 (de) Massenspektrometrische analyse von biopolymeren
US20160349238A1 (en) Method for measuring human exhaled air
DE69736336D1 (de) Verfahren zur messung von blutersatzstoffen
DE60228196D1 (de) System und verfahren zur in-vitro-analyse von therapeutischen wirkstoffen
DE50105263D1 (de) Verfahren zur analyse von proteinen
ATE225942T1 (de) Peptidereagenz zum nachweis von humanem cytomegalovirus (cmv)
WO2004068130A3 (de) Verfahren und vorrichtung zur qualitativen und/oder quantitativen bestimmung eines protein- und/oder peptidmusters einer flüssigkeitsprobe beschrieben, die dem menschlichen oder tierischen körper entnommen wird
ATE262179T1 (de) Verfahren zum nachweis von alpha-oxoaldehyden in vollblut, blutplasma und/oder serum eines patienten
ATE306666T1 (de) Verfahren zur eiweissanalyse
DK0821785T3 (da) Fremgangsmåde til spektroisk analyse af inhomogene prøver
Voelter et al. Capillary electrophoresis in biochemical and clinical laboratories: Selected attractive examples
JPH07151250A (ja) 分岐ラインを制御するための弁